Infusion RCM

Specialized platforms catch infusion billing errors before claims leave the practice.

Infusion centers need RCM platforms built for drug-cost risk, not adapted from general billing.

Infusion practices need specialized RCM vetting criteria to avoid revenue leaks.

Purpose-built platforms prevent denials baked into infusion billing's unique coding mechanics.

High denial rates and systemic RCM failures can erase the earnings buyers are actually paying for.

End-to-end infusion billing requires tracking drug, authorization, and payer rules together.

Knowing which model fits your practice depends on your payer mix and tolerance for inventory risk.

Medicare's narrow Part B benefit leaves most home infusion providers unable to bill profitably.

Practices buy drugs upfront and collect reimbursement later, creating cash flow and margin risk.

Timing and documentation rules separate billable IV push codes from claim denials.

Payers shift drug costs to pharmacies to capture rebates and pricing leverage.

Learn which infusion code takes billing priority and why payers deny routine dual-coding errors.